Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Landgraf

Showing results (11-20 of 395) with videos related to

Pageof 40
Sort By:
Drugs & Aging|February 24, 2001
Meglitinide analogues in the treatment of type 2 diabetes mellitusR Landgraf
Handbook of Experimental Pharmacology|April 6, 2006
Neuropeptides in anxiety modulationR Landgraf
Experimental and Clinical Endocrinology|April 1, 1985
Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocinR Landgraf
ZFA. Zeitschrift Fur Allgemeinmedizin|September 10, 1977
[Forms of diabetic coma]R Landgraf
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 16, 1999
Approaches to the management of postprandial hyperglycaemiaR Landgraf
MMW Fortschritte Der Medizin|August 26, 2000
[Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients]R Landgraf
Der Internist|June 27, 2000
[Peripheral neuropathy in diabetes mellitus from internist's perspective]R Landgraf
Annals of the New York Academy of Sciences|June 14, 1993
PUFA supplementation and hypertension in type 1 diabetesR Landgraf
Stress (Amsterdam, Netherlands)|March 21, 2012
Neuropeptides and anxietyR Landgraf
Der Nervenarzt|March 11, 2003
[Neurobiology and genetics of anxiety in an animal model]R Landgraf
Pageof 40

Showing results (11-20 of 395) with videos related to

Sort By:
Pageof 40
Drugs & Aging|February 24, 2001
Meglitinide analogues in the treatment of type 2 diabetes mellitusR Landgraf
Handbook of Experimental Pharmacology|April 6, 2006
Neuropeptides in anxiety modulationR Landgraf
Experimental and Clinical Endocrinology|April 1, 1985
Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocinR Landgraf
ZFA. Zeitschrift Fur Allgemeinmedizin|September 10, 1977
[Forms of diabetic coma]R Landgraf
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|October 16, 1999
Approaches to the management of postprandial hyperglycaemiaR Landgraf
MMW Fortschritte Der Medizin|August 26, 2000
[Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients]R Landgraf
Der Internist|June 27, 2000
[Peripheral neuropathy in diabetes mellitus from internist's perspective]R Landgraf
Annals of the New York Academy of Sciences|June 14, 1993
PUFA supplementation and hypertension in type 1 diabetesR Landgraf
Stress (Amsterdam, Netherlands)|March 21, 2012
Neuropeptides and anxietyR Landgraf
Der Nervenarzt|March 11, 2003
[Neurobiology and genetics of anxiety in an animal model]R Landgraf
Pageof 40